Cleared Traditional

K933238 - ROTABLATOR, MODIFICATION

K933238 is an FDA 510(k) clearance for ROTABLATOR, manufactured by Heart Technology, Inc.. The device is a Class 2 Cardiovascular device with product code MCW cleared through the Traditional 510(k) pathway after a 70-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1993
Decision
70d
Days
Class 2
Risk

K933238 is an FDA 510(k) clearance for the ROTABLATOR, MODIFICATION. Classified as Catheter, Peripheral, Atherectomy (product code MCW), Class II - Special Controls.

Submitted by Heart Technology, Inc. (Bellevue, US). The FDA issued a Cleared decision on August 24, 1993 after a review of 70 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4875 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K933238

510(k) Number K933238 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 15, 1993
Decision Date August 24, 1993
Days to Decision 70 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
55d faster than avg
Panel avg: 125d · This submission: 70d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MCW Device Classification - Class 2, Special Controls

Product Code MCW Catheter, Peripheral, Atherectomy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4875
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MCW Catheter, Peripheral, Atherectomy

All 145
Devices cleared under the same product code (MCW) and FDA review panel - the closest regulatory comparables to K933238.
ROTABLATOR ROTATIONAL ANGIOPLASTY
K953997 · Heart Technology Mfg., Inc. · Dec 1995
GRAFT THROMBECTOMY INSTRUMENTS
K942457 · Intramed Laboratories, Inc. · Feb 1995
MICROTRACK
K935929 · Devices For Vascular Intervention, Inc. · Mar 1994
INTRA-OPERATIVE TEC ATHERECTOMY SYSTEM
K922970 · Intensive Technology, Inc. · Jan 1993
ROTABLATOR ROTATIONAL ANGIOPLASTY SYSTEM
K924712 · Hearing Tech, Inc. · Dec 1992
HOLLOW MOTOR DRIVE UNIT W/ TORQUE CONTROLLER
K920707 · Devices For Vascular Intervention, Inc. · Nov 1992